Phio Pharmaceuticals Corp.
PHIO· Nasdaq
Released May 15, 2025, after the close
10-Q filed May 15, 2025, 45 days after period end · 0001683168-25-003719
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$1.77M | -$2.15M | -$3.60M | -$2.64M |
| EPS Diluted | -$0.41 | -$0.47 | -$3.15 | -$2.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phio Pharmaceuticals Corp. · CIK 1533040 · Engraved from SEC EDGAR